Convergent Balancing Selection on the Mu-Opioid Receptor in Primates.
The mu opioid receptor is involved in many natural processes including stress response, pleasure, and pain. Mutations in the gene also have been associated with opiate and alcohol addictions as well as with responsivity to medication targeting these disorders. Two common and mutually exclusive polymorphisms have been identified in humans, A118G (N40D), found commonly in non-African populations, and C17T (V6A), found almost exclusively in African populations. Although A118G has been studied extensively for associations and in functional assays, C17T is much less well understood. In addition to a parallel polymorphism previously identified in rhesus macaques (Macaca mulatta), C77G (P26R), resequencing in additional non-human primate species identifies further common variation: C140T (P47L) in cynomolgus macaques (Macaca fascicularis), G55C (D19H) in vervet monkeys (Chlorocebus aethiops sabeus), A111T (L37F) in marmosets (Callithrix jacchus), and C55T (P19S) in squirrel monkeys (Saimiri boliviensis peruviensis). Functional effects on downstream signaling are observed for each of these variants following treatment with the endogenous agonist β-endorphin and the exogenous agonists morphine, DAMGO ([d-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin), and fentanyl. In addition to demonstrating the importance of functional equivalency in reference to population variation for minority health, this also shows how common evolutionary pressures have produced similar phenotypes across species, suggesting a shared response to environmental needs and perhaps elucidating the mechanism by which these organism-environment interactions are mediated physiologically and molecularly. These studies set the stage for future investigations of shared functional polymorphisms across species as a new genetic tool for translational research.
Division of Neuroscience, New England Primate Research Center, Harvard Medical School, Southborough, MA.
Carolyn G
CG
Sweeney
Division of Neuroscience, New England Primate Research Center, Harvard Medical School, Southborough, MA.
Juliette M
JM
Rando
Division of Neuroscience, New England Primate Research Center, Harvard Medical School, Southborough, MA.
Helen N
HN
Panas
Division of Neuroscience, New England Primate Research Center, Harvard Medical School, Southborough, MA.
Gregory M
GM
Miller
Division of Neuroscience, New England Primate Research Center, Harvard Medical School, Southborough, MA.
Donna M
DM
Platt
Division of Neuroscience, New England Primate Research Center, Harvard Medical School, Southborough, MA.
Eric J
EJ
Vallender
D000818:Animals; D005075:Biological Evolution; D019143:Evolution, Molecular; D006801:Humans; D008253:Macaca mulatta / Q000235:genetics; D011110:Polymorphism, Genetic / Q000235:genetics; D011323:Primates / Q000235:genetics; D017450:Receptors, Opioid, mu / Q000235:genetics* / Q000378:metabolism*; D012641:Selection, Genetic / Q000235:genetics
C485764:OPRM1 protein, human; D017450:Receptors, Opioid, mu
balancing selection; molecular evolution; opioid; primates